Diabetes mellitus, type 2 is a medical condition with active clinical research programs worldwide.

27 total trials for this combination

Showing top 10 of 27 trials

Trials

NCT ID	Title	Status	Phase
NCT00399711	Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 Diabetes	COMPLETED	PHASE3
NCT02128932	Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes	COMPLETED	PHASE3
NCT02182830	24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension	COMPLETED	PHASE3
NCT01370005	12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus	COMPLETED	PHASE3
NCT00968708	Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome	COMPLETED	PHASE3
NCT03078478	A Trial Comparing the Efficacy and Safety of Insulin Degludec and Insulin Glargine 300 Units/mL in Subjects With Type 2 Diabetes Mellitus Inadequately Treated With Basal Insulin With or Without Oral Antidiabetic Drugs	COMPLETED	PHASE3
NCT02451137	A Real World Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)	COMPLETED	PHASE4
NCT07064473	EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	RECRUITING	—
NCT02648204	Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.	COMPLETED	PHASE3
NCT02607865	Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes	COMPLETED	PHASE3

Related Pages

All Diabetes mellitus, type 2 trials All trials in Marietta, United States